ShanX Medtech
ShanX Medtech55About
What does ShanX Medtech do?
ShanX Medtech is developing novel diagnostics, specifically an ultra-rapid Antimicrobial Susceptibility Testing (AST) platform. This platform aims to provide sample-to-result turnaround times as fast as 1 hour, significantly reducing the current 2-7 day wait for AST results. By enabling faster identification of effective antibiotics, ShanX Medtech serves clinicians and patients by improving treatment outcomes and combating Antimicrobial Resistance.
What is ShanX Medtech's revenue?
StartupHub estimates ShanX Medtech's annual revenue at $3.7M (range $2.3M to $5.7M, 64% confidence), based on comparable companies in the sector.
What is ShanX Medtech's valuation?
StartupHub estimates ShanX Medtech's effective valuation at $114.4M (range $69.8M to $167.4M, 20% confidence), based on comparable companies in the sector.
How much funding has ShanX Medtech raised?
ShanX Medtech has raised a total of $28M in funding. The most recent round on record is Seed.
Where is ShanX Medtech headquartered?
ShanX Medtech is headquartered in San Diego, United States.
When was ShanX Medtech founded?
ShanX Medtech was founded in 2019.
What industry does ShanX Medtech operate in?
ShanX Medtech operates in HealthTech, Biotechnology, Diagnostics, MedTech, In-Vitro Diagnostics, Antimicrobial Resistance.
How many employees does ShanX Medtech have?
ShanX Medtech has approximately 16 people on record.
No comments yet. Be the first to share your take.